Similar articles for PMID: 15479440

Year	Number of Results
1996	2
1997	2
1998	4
1999	2
2000	1
2001	3
2003	3
2004	2
2005	2
2006	4
2007	7
2008	5
2009	6
2010	6
2011	8
2012	8
2013	5
2014	6
2015	10
2016	5
2017	7
2018	9
2019	5
2020	3
2021	1
2022	0

1

Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.

Aguilar JC, Lobaina Y, Muzio V, García D, Pentón E, Iglesias E, Pichardo D, Urquiza D, Rodríguez D, Silva D, Petrovsky N, Guillén G. Aguilar JC, et al. Immunol Cell Biol. 2004 Oct;82(5):539-46. doi: 10.1111/j.0818-9641.2004.01278.x. Immunol Cell Biol. 2004. PMID: 15479440

2

Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.

Li J, Ge J, Ren S, Zhou T, Sun Y, Sun H, Gu Y, Huang H, Xu Z, Chen X, Xu X, Zhuang X, Song C, Jia F, Xu A, Yin X, Du SX. Li J, et al. Vaccine. 2015 Aug 20;33(35):4247-54. doi: 10.1016/j.vaccine.2015.03.079. Epub 2015 Apr 6. Vaccine. 2015. PMID: 25858855

3

Nasal route favors the induction of CD4⁺ T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccine.

Bourgine M, Crabe S, Lobaina Y, Guillen G, Aguilar JC, Michel ML. Bourgine M, et al. Antiviral Res. 2018 May;153:23-32. doi: 10.1016/j.antiviral.2018.02.019. Epub 2018 Mar 3. Antiviral Res. 2018. PMID: 29510155

4

Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.

Akbar SM, Chen S, Al-Mahtab M, Abe M, Hiasa Y, Onji M. Akbar SM, et al. Antiviral Res. 2012 Oct;96(1):59-64. doi: 10.1016/j.antiviral.2012.07.011. Epub 2012 Aug 1. Antiviral Res. 2012. PMID: 22884884

5

Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.

Wang S, Qiu L, Liu G, Li Y, Zhang X, Jin W, Gao GF, Kong X, Meng S. Wang S, et al. Vaccine. 2011 Aug 26;29(37):6342-51. doi: 10.1016/j.vaccine.2011.05.008. Epub 2011 May 19. Vaccine. 2011. PMID: 21600951

6

Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.

Mahdavi M, Mavandadnejad F, Yazdi MH, Faghfuri E, Hashemi H, Homayouni-Oreh S, Farhoudi R, Shahverdi AR. Mahdavi M, et al. J Infect Public Health. 2017 Jan-Feb;10(1):102-109. doi: 10.1016/j.jiph.2016.02.006. Epub 2016 Mar 23. J Infect Public Health. 2017. PMID: 27026241 Free article.

7

Recombinant hepatitis B core antigen carrying preS1 epitopes induce immune response against chronic HBV infection.

Chen X, Li M, Le X, Ma W, Zhou B. Chen X, et al. Vaccine. 2004 Jan 2;22(3-4):439-46. doi: 10.1016/j.vaccine.2003.07.014. Vaccine. 2004. PMID: 14670326

8

Comparative study of the immunogenicity and immunoenhancing effects of two hepatitis B core antigen variants in mice by nasal administration.

Lobaina Y, Palenzuela D, García D, Rodríguez D, Pichardo D, Muzio V, Aguilar JC. Lobaina Y, et al. Vaccine. 2006 Apr 12;24 Suppl 2:S2-58-9. doi: 10.1016/j.vaccine.2005.01.122. Vaccine. 2006. PMID: 16823928

9

Lentiviral vector encoding ubiquitinated hepatitis B core antigen induces potent cellular immune responses and therapeutic immunity in HBV transgenic mice.

Dai S, Zhuo M, Song L, Chen X, Yu Y, Zang G, Tang Z. Dai S, et al. Immunobiology. 2016 Jul;221(7):813-21. doi: 10.1016/j.imbio.2016.01.015. Epub 2016 Feb 2. Immunobiology. 2016. PMID: 26874581

10

A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.

Buchmann P, Dembek C, Kuklick L, Jäger C, Tedjokusumo R, von Freyend MJ, Drebber U, Janowicz Z, Melber K, Protzer U. Buchmann P, et al. Vaccine. 2013 Feb 6;31(8):1197-203. doi: 10.1016/j.vaccine.2012.12.074. Epub 2013 Jan 7. Vaccine. 2013. PMID: 23306359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed